Reporter

Potential AML therapy induces leukemic stem cell death

Vanderbilt researchers are studying a potential therapy for acute myeloid leukemia that targets the residual leukemic stem cells in bone marrow after treatment that are responsible for relapses and drug resistance.

C.J. Stimson named Executive Vice President for Population Health

C.J. Stimson, MD, JD, assistant professor of Urology and Senior Vice President of Value Transformation in the Vanderbilt University Medical Center Office of Population Health, has been named Executive Vice President for Population Health.

David Posch assumes new role of Senior Vice President for Business Consulting

David Posch, MA, Executive Vice President for Vanderbilt University Medical Center’s (VUMC) Office of Population Health and Executive Director for Vanderbilt Health Affiliated Network (VHAN), has transitioned into the new role of Senior Vice President for Business Consulting

Team uses COVID-19 to test automated acute disease profiling

An automated solution for creating phenotyping algorithms, PheNorm, worked well to identify symptomatic COVID-19 cases in electronic health records, suggesting that automation could speed high-throughput phenotyping of acute disease.

Fruits of their labor

Attending and resident physicians, nurses, other clinical staff and their families recently inspected, sorted and packaged frozen food and produce at Second Harvest Food Bank as part of Vanderbilt Orthopaedics Community Service Day.

Glucose metabolism influences B cell function

Glucose metabolism influences the qualities of activated, mature B cells — white blood cells that are required for antibody-mediated immune responses, Vanderbilt researchers discovered.

1 9 10 11 12 13 725